Liquid chromatography-tandem mass spectrometry analysis of nitazoxanide and its major metabolites in goat

被引:24
作者
Zhao, Zhanzhong [1 ]
Zhang, Lifang [1 ]
Xue, Feiqun [1 ]
Wang, Xiaoyang [1 ]
Zheng, Wenli [1 ]
Zhang, Tao [1 ]
Fei, Chenzhong [1 ]
Zhang, Keyu [1 ]
Qiu, Minqi [1 ]
Xin, Ruixiang [1 ]
Yang, Fengkun [1 ]
机构
[1] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Dept Pharm, Shanghai 200232, Peoples R China
来源
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES | 2008年 / 875卷 / 02期
关键词
Nitazoxanide; Metabolites; LC-MS-MS; Goat;
D O I
10.1016/j.jchromb.2008.09.017
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid, sensitive and specific liquid chromatography-electrospray ionization (ESI) tandem mass spectrometry (LC-MS-MS) method has been developed for the identification of nitazoxanide metabolites in goat plasma and urine. The purified samples was separated using an XTerra MS C8 column with the mobile phase consisted of acetonitrile and 10-mM ammonium acetate buffer (pH 2.5) followed a linear gradient elution, and detected by MS-MS. Identification and structural elucidation of the metabolites were performed by comparing their retention-times, full scan, product ion scan, precursor ion scan and neutral loss scan MS-MS spectra with those of the parent drug or other available standard. Four metabolites (tizoxanide, tizoxanide glucuronide, tizoxanide sulfate and hydroxylated tizoxanide sulfate) were found and identified in goat after single oral administration of 200 mg/kg dose of nitazoxanide. In addition, the possible metabolic pathway was proposed for the first time. The results proved that the established method was simple, reliable and sensitive, revealing that it could be used to rapid screen and identify the structures of active metabolites responsible for pharmacological effects of nitazoxanide and to better understand its in vivo metabolism. (c) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:427 / 436
页数:10
相关论文
共 31 条
[11]   An open-label clinical study of nitazoxanide in the treatment of human fascioliasis [J].
Kabil, SM ;
El Ashry, E ;
Ashraf, NK .
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2000, 61 (06) :339-345
[12]   Nitazoxanide, tizoxanide and other thiazolides are potent inhibitors of hepatitis B virus and hepatitis C virus replication [J].
Korba, Brent E. ;
Montero, Abigail B. ;
Farrar, Kristine ;
Gaye, Karen ;
Mukerjee, Sampa ;
Ayers, Marc S. ;
Rossignol, Jean-Francois .
ANTIVIRAL RESEARCH, 2008, 77 (01) :56-63
[13]   Nitazoxanide, a potential drug for eradication of Helicobacter pylori with no cross-resistance to metronidazole [J].
Mégraud, F ;
Occhialini, A ;
Rossignol, JF .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) :2836-2840
[14]   UDP GLUCURONYLTRANSFERASE AND PHENOLSULFOTRANSFERASE INVIVO AND INVITRO - CONJUGATION OF HARMOL AND HARMALOL [J].
MULDER, GJ ;
HAGEDOORN, AH .
BIOCHEMICAL PHARMACOLOGY, 1974, 23 (15) :2101-2109
[15]  
Oliveira EJ, 2000, BIOMED CHROMATOGR, V14, P351, DOI 10.1002/1099-0801(200010)14:6<351::AID-BMC28>3.0.CO
[16]  
2-2
[17]  
POON GK, 1997, ELECTROSPRAY IONIZAT, P499
[18]  
*PROD INF AL, 2002, ROM PHARM AL NIT OR
[19]   Nitazoxanide in the treatment of viral gastroenteritis: a randomized double-blind placebo-controlled clinical trial [J].
Rossignol, J. -F. ;
El-Gohary, Y. M. .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2006, 24 (10) :1423-1430
[20]   Effect of nitazoxanide for treatment of severe rotavirus diarrhoea: randomised double-blind placebo-controlled trial [J].
Rossignol, JF ;
Abu-Zekry, M ;
Hussein, A ;
Santoro, MG .
LANCET, 2006, 368 (9530) :124-129